BioXcel Therapeutics Dividend
Dividend criteria checks 0/6
BioXcel Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$4.83 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
BioXcel Therapeutics: Igalmi's Commercial Uncertainty Remains, Downgrading To A Hold
Aug 28BioXcel Therapeutics Q2 2022 Earnings Preview
Aug 08BioXcel Therapeutics: BXCL501 For Acute Agitation In Patients With Dementia And Alzheimer's - A Great Asset
Jul 19BioXcel's Igalmi: Potential Market For Acute Agitation In Esquizofrenia And Bipolar Patients
May 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BTAI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BTAI's dividend payments have been increasing.
Dividend Yield vs Market
| BioXcel Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BTAI) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (BTAI) | 0% |
Notable Dividend: Unable to evaluate BTAI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BTAI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BTAI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BTAI has not reported any payouts.